Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 181

1.

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis.

Harrison SA, Rossi SJ, Paredes AH, Trotter JF, Bashir MR, Guy CD, Banerjee R, Jaros MJ, Owers S, Baxter BA, Ling L, DePaoli AM.

Hepatology. 2019 Feb 25. doi: 10.1002/hep.30590. [Epub ahead of print]

PMID:
30805949
2.

An Atypical Biliary Fistula in a Liver Transplant Recipient.

Alsahhar JS, Hansen D, Page J, Sandkovsky U, Burdick S, Trotter JF, Rahimi RS.

Liver Transpl. 2019 Jan 28. doi: 10.1002/lt.25416. [Epub ahead of print] No abstract available.

PMID:
30693637
3.

Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.

Rinella ME, Trotter JF, Abdelmalek MF, Paredes AH, Connelly MA, Jaros MJ, Ling L, Rossi SJ, DePaoli AM, Harrison SA.

J Hepatol. 2019 Apr;70(4):735-744. doi: 10.1016/j.jhep.2018.11.032. Epub 2018 Dec 8.

4.

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.

Hirschfield GM, Chazouillères O, Drenth JP, Thorburn D, Harrison SA, Landis CS, Mayo MJ, Muir AJ, Trotter JF, Leeming DJ, Karsdal MA, Jaros MJ, Ling L, Kim KH, Rossi SJ, Somaratne RM, DePaoli AM, Beuers U.

J Hepatol. 2019 Mar;70(3):483-493. doi: 10.1016/j.jhep.2018.10.035. Epub 2018 Nov 9.

5.

A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction.

Asrani SK, Jennings LW, Trotter JF, Levitsky J, Nadim MK, Kim WR, Gonzalez SA, Fischbach B, Bahirwani R, Emmett M, Klintmalm G.

Hepatology. 2019 Mar;69(3):1219-1230. doi: 10.1002/hep.30321. Epub 2019 Feb 20.

PMID:
30338870
6.

Case Report of a Rare Presentation of Isolated Cytomegalovirus Hepatitis After Renal Transplantation.

Soape MP, Rahimi RS, Spak CW, Trotter JF.

Prog Transplant. 2018 Sep;28(3):296-298. doi: 10.1177/1526924818781573. Epub 2018 Jun 13. No abstract available.

PMID:
29898621
7.

Elastography and the Risk of Hepatocellular Carcinoma.

Trotter JF.

Gastroenterol Hepatol (N Y). 2018 Feb;14(2):108-110. No abstract available.

8.

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Harrison SA, Rinella ME, Abdelmalek MF, Trotter JF, Paredes AH, Arnold HL, Kugelmas M, Bashir MR, Jaros MJ, Ling L, Rossi SJ, DePaoli AM, Loomba R.

Lancet. 2018 Mar 24;391(10126):1174-1185. doi: 10.1016/S0140-6736(18)30474-4. Epub 2018 Mar 5. Erratum in: Lancet. 2018 Mar 24;391(10126):e16.

PMID:
29519502
9.

The diminishing role of liver biopsy in living donor liver transplantation.

Trotter JF.

Liver Transpl. 2018 Apr;24(4):457-458. doi: 10.1002/lt.25038. No abstract available.

PMID:
29466831
10.

Pro: Direct-acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma.

Trotter JF.

Liver Transpl. 2017 Dec;23(12):1593-1595. doi: 10.1002/lt.24960. No abstract available.

11.

The rise of the opioid epidemic and hepatitis C-positive organs: A new era in liver transplantation.

Gonzalez SA, Trotter JF.

Hepatology. 2018 Apr;67(4):1600-1608. doi: 10.1002/hep.29572. Epub 2018 Mar 4. Review.

PMID:
29023920
12.

Controversies in liver transplantation: A new series for the journal.

Trotter JF.

Liver Transpl. 2017 Oct;23(10):1255. doi: 10.1002/lt.24860. No abstract available.

13.

Rational Heart Transplant From a Hepatitis C Donor: New Antiviral Weapons Conquer the Trojan Horse.

Gottlieb RL, Sam T, Wada SY, Trotter JF, Asrani SK, Lima B, Joseph SM, Gonzalez-Stawinski GV, Hall SA.

J Card Fail. 2017 Oct;23(10):765-767. doi: 10.1016/j.cardfail.2017.08.448. Epub 2017 Aug 8.

14.

The Living Donor Collective: A Scientific Registry for Living Donors.

Kasiske BL, Asrani SK, Dew MA, Henderson ML, Henrich C, Humar A, Israni AK, Lentine KL, Matas AJ, Newell KA, LaPointe Rudow D, Massie AB, Snyder JJ, Taler SJ, Trotter JF, Waterman AD; Living Donor Collective participants.

Am J Transplant. 2017 Dec;17(12):3040-3048. doi: 10.1111/ajt.14365. Epub 2017 Jun 22.

15.

Controversies in Liver Transplantation.

Trotter JF.

Gastroenterol Hepatol (N Y). 2017 Feb;13(2):133-135. No abstract available.

16.

Liver transplantation around the world.

Trotter JF.

Curr Opin Organ Transplant. 2017 Apr;22(2):123-127. doi: 10.1097/MOT.0000000000000392. Review.

PMID:
28151809
17.

An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.

Trotter JF.

Hepatology. 2017 Jan;65(1):15-17. doi: 10.1002/hep.28913. Epub 2016 Nov 29. No abstract available.

PMID:
27813119
18.

Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study.

Fortune BE, Garcia-Tsao G, Ciarleglio M, Deng Y, Fallon MB, Sigal S, Chalasani NP, Lim JK, Reuben A, Vargas HE, Abrams G, Lewis MD, Hassanein T, Trotter JF, Sanyal AJ, Beavers KL, Ganger D, Thuluvath PJ, Grace ND, Groszmann RJ; Vapreotide Study Group.

J Clin Gastroenterol. 2017 May/Jun;51(5):446-453. doi: 10.1097/MCG.0000000000000733.

20.

Liver transplantation around the world.

Trotter JF, Cárdenas A.

Liver Transpl. 2016 Aug;22(8):1059-61. doi: 10.1002/lt.24508. No abstract available.

Supplemental Content

Loading ...
Support Center